A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...

A blood abnormality detected five decades ago has finally been solved, confirming the discovery of a new blood type.

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients and Present Updated ...

A new study has introduced an innovative approach to CAR-T therapy that could address some of the current challenges in ...

Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized ...

The following is a summary of “Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 ...

Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic ...

FWMOH operates nine locations across northeastern Indiana and is staffed by 16 Board-certified medical oncologists and two ...

FlowScore is a new, cost-effective metric for assessing red blood cell quality, improving oxygen delivery evaluation in blood ...

An antitumor biomedical cell product based on natural killer cells has been registered in Belarus. The technology was ...